Search

everythinglearnresearchcommunity

for

Search:↓

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Hair loss treatment caused more hair loss in a man.

Genetically modified cells improved skin wound healing in rats.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

RCS-01 cell therapy is safe and improves skin gene expression.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Genetically modified umbilical cord blood cells improved skin wound healing in rats.

A new skin treatment using a patient's own cells healed chronic wounds effectively and was preferred over traditional grafts.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

The humanized AA mouse model is better for testing new alopecia areata treatments.

The role of γδT-cells in causing alopecia areata remains unclear.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

HGF-modified hair follicle stem cells help brain recovery after injury in rats.

Cardiac xenotransplantation is moving towards clinical use with growing research and collaboration.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Topical cyclosporine significantly extends skin graft survival in rats.

Regenerative hair transplant improves hair growth and quality using stem cells.

Male-to-female skin grafts in mice are rejected due to sex-linked antigens.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Peanut allergies can be transferred through organ transplants.

StemMACS media is better for growing therapeutic stem cells than PowerStem media.